Legal status (US): BPC-157 has no FDA-approved indication
All handling should be performed in a sterile laboratory environment using appropriate aseptic techniques
Small clinical trials have shown improvements with both oral and IV glutathione
For weight management indications, prescribing guidelines generally require a BMI of 30 or above, or 27 or above with at least one comorbidity such as type-2 diabetes, hypertension, dyslipidaemia, or obstructive sleep apnoea
Research has documented MT-IIs potent, dose-dependent pro-erectile effects in rodent, rabbit, and non-human primate models , with studies characterising ex copula erection frequency, latency to erection, and duration of response following MT-II administration at doses producing reliable and reproducible pro-erectile responses